Send feedback

ELP1 p.Arg696Pro

c.2087G>C · rs137853022 · VCV6086

Pathogenic/Likely pathogenic Multiple submitters
Classification
Pathogenic/Likely pathogenic
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 10 submitters
AlphaMissense
likely pathogenic
0.9811 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000274%)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
3
Riley-Day syndrome

Computational evidence

Protein change
AlphaMissense0.9811likely pathogenic ✓ concordant with ClinVar · top 1% in ELP1
REVEL0.539indeterminate
SaProtLLR -16.86damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 5.9GERP 1.7, phastCons 1
Regional constrainto/e 0.97unconstrained · MANE · 62 kb · p 0.26 · regional, not allelic
Overall
CADD27.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000274%
Overall 0.000274% 4/1,461,856 alleles · very rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0101% 9,869
Remaining individualsnot grpmax-eligible 0.0016% 62,508

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ELP1
Protein
p.Arg696Pro
Coding
c.2087G>C
MANE Select
NM_003640
dbSNP
rs137853022
Type
single nucleotide variant
Location
chr9:108900303 (GRCh38)
Gene constraint
LOEUF 0.803 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 84.31 · 5 PDB
Residue 696
a β-strand; a UniProt-annotated variant site (in fd; mild phenotype; phosphorylation is reduced; does not affect interaction with elp2; reduced interaction with elp3; does not affect dimerization)
Full ELP1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Riley-Day syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: medulloblastomaCharcot-Marie-Tooth disease

For Familial dysautonomia (Orphanet):

Inheritance
Autosomal recessive
Onset
Childhood, Infancy, Neonatal
Prevalence
<1 / 1 000 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/elp1-p-arg696pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown